David Kim is a Cardiology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
100 Spalding Dr Ste 400
Naperville, IL 605406554
Telephone
630-718-2660Provider last certified this registry record 9 Aug 2023.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- DePuy Synthes Sales Inc.Program year202511 payments
- Boston Scientific CorporationProgram year20255 payments
- Amgen Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85%Statin25%Rosuvastatin Calcium50%Atorvastatin Calcium49%Simvastatin1%Pravastatin Sodium1%Part D<11 patientsBeta blocker20.6%Metoprolol Succinate70%Carvedilol18%Metoprolol Tartrate9%Atenolol1%Labetalol Hcl1%Sotalol1%Propranolol Hcl1%Part D<11 patients+ 19 more classes in this area
Blood & clotting
14.3%Factor Xa inhibitor7.8%Eliquis73%Xarelto27%Part D≥155 patientsP2Y12 inhibitor4.8%Clopidogrel87%Brilinta13%Part D≥130 patients+ 1 more class in this area
Metabolism & gastrointestinal
0.7%SGLT2 inhibitor0.5%Jardiance100%Part D≥12 patientsPotassium supplement0.3%Potassium Chloride100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- Modeling Long-Term Health and Economic Impacts of National Strategies to Address Food and Nutrition Insecurity
University of Chicago
FY2026$1,342,225R01MD019094 - Development and Validation of the U.S. Oral Health Microsimulation Model
University of Chicago
FY2026$328,000R03DE036026 - Modeling Long-Term Health and Economic Impacts of National Strategies to Address Food and Nutrition Insecurity
University of Chicago
FY2025$687,592R01MD019094
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”